Structures by: Kalluraya B.
Total: 164
5-(2,4-Dichlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H12Cl2N2O2
IUCrData (2016) 1, 7 x161111
a=10.113(8)Å b=13.278(10)Å c=12.224(10)Å
α=90° β=102.219(15)° γ=90°
Ethyl (naphthalen-2-yloxy)acetate
C14H14O3
IUCrData (2016) 1, 10 x161594
a=6.0504(11)Å b=10.2188(13)Å c=10.8744(16)Å
α=106.062(12)° β=102.923(14)° γ=103.358(14)°
5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H13ClN2O2
Acta Crystallographica Section C (2019) 75, 6
a=10.3034(4)Å b=11.4856(4)Å c=14.4725(5)Å
α=81.013(2)° β=69.861(2)° γ=69.990(2)°
3-Methyl-5-(naphthalen-2-yloxy)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C21H16N2O2
Acta Crystallographica Section C (2019) 75, 6
a=7.7302(6)Å b=17.2550(16)Å c=13.1989(11)Å
α=90° β=106.079(2)° γ=90°
3-Methyl-5-(4-nitrophenoxy)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H13N3O4
Acta Crystallographica Section C (2019) 75, 6
a=14.1163(9)Å b=11.7268(7)Å c=9.3982(5)Å
α=90° β=94.259(3)° γ=90°
3-Methyl-1-phenyl-5-(piperidin-1-yl)-1<i>H</i>-pyrazole-4-carbaldehyde
C16H19N3O
Acta Crystallographica Section C (2019) 75, 6
a=8.9432(7)Å b=16.0546(14)Å c=10.1155(8)Å
α=90° β=97.777(2)° γ=90°
(3<i>RS</i>)-2-Acetyl-5-(4-azidophenyl)-5'-(2-chlorophenoxy)-3'-methyl-1'-phenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole]
C27H22ClN7O2
Acta Crystallographica Section C (2019) 75, 6
a=10.8804(4)Å b=11.3363(4)Å c=11.5737(4)Å
α=97.294(2)° β=90.050(2)° γ=117.840(2)°
(3<i>RS</i>)-2-Acetyl-5-(4-azidophenyl)-3'-methyl-5'-(naphthalen-2-yloxy)-1'-phenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole]
C31H25N7O2
Acta Crystallographica Section C (2019) 75, 6
a=10.4911(11)Å b=11.2048(12)Å c=13.5943(17)Å
α=105.323(3)° β=93.505(3)° γ=117.460(3)°
Diethyl (<i>RS</i>)-2-[(4-chlorophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25ClN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5609(8)Å b=20.2800(10)Å c=17.7280(10)Å
α=90° β=95.363(5)° γ=90°
Diethyl (<i>RS</i>)-2-[(4-bromophenyl)(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)methyl]propanedioate
C24H25BrN2O5
Acta Crystallographica Section E (2020) 76, 10 1605-1610
a=13.5644(5)Å b=20.3405(7)Å c=17.4818(8)Å
α=90° β=94.858(4)° γ=90°
<i>N</i>-{[4-(3-phenyl-4-sydnonylideneamino)-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl]methyl}benzamide ethanol monosolvate
C19H15N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.6313(6)Å b=10.8378(9)Å c=13.3840(10)Å
α=66.645(8)° β=79.287(8)° γ=85.151(8)°
<i>N</i>-({4-[3-(4-Methylphenyl)-4-sydnonylideneamino]-5-sulfanylidene-1<i>H</i>-1,2,4-triazol-3-yl}methyl)benzamide ethanol monosolvate
C20H17N7O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 7 1057-1061
a=8.5631(5)Å b=11.1242(8)Å c=13.5632(9)Å
α=70.244(6)° β=76.086(7)° γ=84.058(6)°
3-[5-(2-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-yn-1-yloxy)phenyl]prop-2-en-1-one
C28H21ClN2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=9.909(7)Å b=10.193(6)Å c=12.024(8)Å
α=90.94(2)° β=106.27(2)° γ=92.75(2)°
3-[3-Methyl-5-(naphthalen-2-yloxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-ynyloxy)phenyl]prop-2-en-1-one
C32H24N2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=8.8615(6)Å b=10.4973(7)Å c=13.6588(10)Å
α=79.006(3)° β=89.412(3)° γ=80.971(3)°
1-(4-Azidophenyl)-3-[3-methyl-5-(2-methylphenoxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-one
C26H21N5O2
Acta Crystallographica Section E (2020) 76, 5 683-691
a=9.8432(6)Å b=11.7441(7)Å c=12.3005(7)Å
α=114.120(2)° β=111.139(2)° γ=96.537(2)°
1-(4-Azidophenyl)-3-[5-(2,4-dichlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-one
C25H17Cl2N5O2
Acta Crystallographica Section E (2020) 76, 5 683-691
a=28.1916(17)Å b=8.0537(5)Å c=22.0446(12)Å
α=90° β=109.0700(10)° γ=90°
1-(4-Bromophenyl)-3-[4-(prop-2-ynyloxy)phenyl]prop-2-en-1-one
C18H13BrO2
Acta Crystallographica Section E (2020) 76, 3 360-365
a=18.286(6)Å b=14.277(4)Å c=5.8489(17)Å
α=90° β=94.521(7)° γ=90°
1-(4-Chlorophenyl)-3-[4-(prop-2-ynyloxy)phenyl]prop-2-en-1-one
C18H13ClO2
Acta Crystallographica Section E (2020) 76, 3 360-365
a=17.990(3)Å b=14.2529(16)Å c=5.8661(8)Å
α=90° β=94.419(4)° γ=90°
(<i>RS</i>)-3-(4-Bromophenyl)-5-[4-(prop-2-ynyloxy)phenyl]-4,5-dihydropyrazole-1-carbothioamide
C19H16BrN3OS
Acta Crystallographica Section E (2020) 76, 3 360-365
a=15.1255(13)Å b=6.0426(5)Å c=21.026(2)Å
α=90° β=110.555(3)° γ=90°
(<i>RS</i>)-3-(4-Chlorophenyl)-5-[4-(prop-2-ynyloxy)phenyl]-4,5-dihydropyrazole-1-carbothioamide
C19H16ClN3OS
Acta Crystallographica Section E (2020) 76, 3 360-365
a=15.0182(9)Å b=6.0579(3)Å c=20.8286(12)Å
α=90° β=110.573(2)° γ=90°
(<i>RS</i>)-3-(4-Methoxyphenyl)-5-[4-(prop-2-ynyloxy)phenyl]-4,5-dihydropyrazole-1-carbothioamide
C20H19N3O2S
Acta Crystallographica Section E (2020) 76, 3 360-365
a=11.7852(15)Å b=7.5345(11)Å c=20.599(3)Å
α=90° β=93.555(4)° γ=90°
3-(3-Methyl-5-phenoxy-1-phenyl-1<i>H</i>-pyrazol-4-yl)-1-(thiophen-2-yl)prop-2-en-1-one
C23H18N2O2S
Acta Crystallographica Section E (2020) 76, 1 48-52
a=9.6158(5)Å b=19.8846(11)Å c=10.3773(6)Å
α=90° β=93.712(2)° γ=90°
3-[3-Methyl-5-(2-methylphenoxy)-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-(thiophen-2-yl)prop-2-en-1-one
C24H20N2O2S
Acta Crystallographica Section E (2020) 76, 1 48-52
a=9.4336(4)Å b=20.6071(9)Å c=10.5866(4)Å
α=90° β=93.106(2)° γ=90°
1-Phenyl-1<i>H</i>-pyrazole-3,4-dicarboxylic acid
C11H8N2O4
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=13.164(2)Å b=7.4692(9)Å c=21.173(3)Å
α=90° β=90° γ=90°
Dimethyl 1-phenyl-1<i>H</i>-pyrazole-3,4-dicarboxylate
C13H12N2O4
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=5.9000(4)Å b=14.5273(12)Å c=14.8726(12)Å
α=90° β=98.867(3)° γ=90°
Dimethyl 1-(4-methylphenyl)-1<i>H</i>-pyrazole-3,4-dicarboxylate
C14H14N2O4
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=7.6546(5)Å b=8.0959(5)Å c=11.3065(6)Å
α=78.988(3)° β=85.527(3)° γ=87.548(4)°
(<i>E</i>)-<i>N</i>'-[4-(Dimethylamino)benzylidene]-2-(4-methylphenoxy)acetohydrazide
C18H21N3O2
Acta Crystallographica Section E (2014) 70, 2 o140
a=11.2237(6)Å b=9.4471(5)Å c=15.8785(9)Å
α=90° β=100.868(3)° γ=90°
4-(4-Methylphenyl)-2-(prop-2-yn-1-yl)phthalazin-1(2<i>H</i>)-one
C18H14N2O
Acta Crystallographica Section E (2014) 70, 2 o138
a=11.9917(19)Å b=9.7116(16)Å c=12.602(2)Å
α=90° β=101.285(7)° γ=90°
5-(4-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C17H13ClN2O2
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 5 o560
a=9.1016(7)Å b=7.5298(6)Å c=22.1242(16)Å
α=90° β=93.908(3)° γ=90°
5-[(2-Methyl-4-nitro-1<i>H</i>-imidazol-1-yl)methyl]-1,3,4-thiadiazol-2-amine
C7H8N6O2S
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 12 o1825
a=7.8030(15)Å b=8.2750(16)Å c=8.3596(16)Å
α=100.945(8)° β=92.379(8)° γ=105.911(7)°
Imidazoacethydrazone
C15H17N5O3
Acta Crystallographica Section E (2006) 62, 3 o1126-o1128
a=8.423(2)Å b=10.577(4)Å c=17.97(3)Å
α=90° β=89.46(8)° γ=90°
3-Ethyl-6-{1-[4-(2-methylpropyl)phenyl]ethyl}-1,2,4- triazolo[3,4-b][1,3,4]thiadiazole
C17H22N4S
Acta Crystallographica Section E (2008) 64, 9 o1838-o1839
a=11.4341(5)Å b=9.1939(4)Å c=30.9870(13)Å
α=90.00° β=90.00° γ=90.00°
4-Chloro-<i>N</i>'-[(<i>Z</i>)-4-nitrobenzylidene]benzohydrazide monohydrate
C14H10ClN3O3,H2O
Acta Crystallographica Section E (2008) 64, 9 o1707
a=16.3049(8)Å b=6.8783(4)Å c=12.7209(7)Å
α=90.00° β=104.122(4)° γ=90.00°
1,5-(4-Dichlorophenyl)-3-(2,5-dimethoxyphenyl)pentane-1,5-dione
C25H22Cl2O4
Acta Crystallographica Section E (2006) 62, 11 o5024-o5026
a=23.4679(8)Å b=5.6373(2)Å c=16.5149(5)Å
α=90.00° β=96.104(2)° γ=90.00°
Pyrimidine derivative
C16H13ClN4O
Acta Crystallographica Section E (2007) 63, 6 o2911-o2911
a=7.2458(2)Å b=13.6704(4)Å c=14.4757(3)Å
α=90.718(2)° β=92.618(2)° γ=93.6230(10)°
Pyrimidine derivative
C14H9BrN4O
Acta Crystallographica Section E (2007) 63, 8 o3362-o3362
a=15.1590(3)Å b=6.4761(2)Å c=13.1979(3)Å
α=90° β=90.584(2)° γ=90°
Pyrimidine derivative
C14H19N5O2S2
Acta Crystallographica Section E (2007) 63, 8 o3425-o3425
a=7.1250(3)Å b=10.6735(3)Å c=12.3740(5)Å
α=93.607(2)° β=90.561(2)° γ=107.474(2)°
2-Bromo-3-ethoxy-3-[4-(methylsulfanyl)phenyl]-1-[3-(<i>p</i>-tolyl)-4-\ sydnonyl]propan-1-one
C21H21BrN2O4S
Acta Crystallographica Section E (2007) 63, 10 o3976-o3976
a=24.420(3)Å b=12.3883(13)Å c=18.3113(19)Å
α=90° β=127.5640(10)° γ=90°
4-(4-Bromobenzylideneamino)-1-(diphenylaminomethyl)-3-[1-(4- isobutylphenyl)ethyl]-1H-1,2,4-triazole-5(4H)-thione
C34H34BrN5S
Acta Crystallographica Section E (2008) 64, 6 o1001-o1002
a=10.96720(10)Å b=9.78330(10)Å c=28.6210(3)Å
α=90.00° β=105.9660(10)° γ=90.00°
4-[(<i>E</i>)-4-Bromobenzylideneamino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(3H)-thione
C10H9BrN4S
Acta Crystallographica Section E (2008) 64, 8 o1509
a=6.9239(5)Å b=7.6072(5)Å c=11.5982(8)Å
α=82.453(5)° β=88.339(5)° γ=68.204(4)°
4-[(<i>E</i>)-2-Furylmethyleneamino]-3-phenyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C13H10N4OS
Acta Crystallographica Section E (2008) 64, 8 o1528-o1529
a=27.4006(6)Å b=11.4940(3)Å c=7.7886(2)Å
α=90.00° β=90.00° γ=90.00°
4-Chloro-<i>N</i>'-[(<i>Z</i>)-4-(dimethylamino)benzylidene]benzohydrazide monohydrate
C16H16ClN3O,H2O
Acta Crystallographica Section E (2008) 64, 8 o1594-o1595
a=6.44180(10)Å b=6.93440(10)Å c=33.8083(7)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2-bromo-5-fluorophenyl)-6-methyl-1-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C20H18BrFN2O2S
Acta Crystallographica Section E (2008) 64, 8 o1526-o1527
a=10.04550(10)Å b=10.29690(10)Å c=10.37140(10)Å
α=64.2860(10)° β=83.1100(10)° γ=78.7960(10)°
4-Amino-3-{1-[4-(2-methylpropyl)phenyl]ethyl}-1<i>H</i>-1,2,4-triazole-5(4H)-thione
C14H20N4S
Acta Crystallographica Section E (2008) 64, 8 o1590-o1591
a=5.9720(3)Å b=8.5153(5)Å c=14.8271(6)Å
α=90.00° β=97.223(3)° γ=90.00°
4-[(<i>E</i>)-2,6-Dichlorobenzylideneamino]-3-{1-[4-(2-methylpropyl)phenyl]ethyl}-1<i>H</i>-1,2,4-triazole-5(4H)-thione
C21H22Cl2N4S
Acta Crystallographica Section E (2008) 64, 8 o1503-o1504
a=8.6190(2)Å b=9.4441(2)Å c=14.4244(4)Å
α=104.669(2)° β=95.492(2)° γ=110.4180(10)°
4-(4-Bromobenzylideneamino)-3-{1-[4-(2-methylpropyl)phenyl]ethyl}-1- (morpholinomethyl)-1<i>H</i>-1,2,4-triazole-5(4H)-thione
C26H32BrN5OS
Acta Crystallographica Section E (2008) 64, 8 o1570-o1571
a=10.13810(10)Å b=17.0356(2)Å c=17.2077(2)Å
α=64.1680(10)° β=79.7730(10)° γ=78.8160(10)°
Pyrimidine derivative
C14H10Br2N6O
Acta Crystallographica Section E (2008) 64, 2 o362-o362
a=9.1647(3)Å b=12.2833(5)Å c=14.0288(5)Å
α=86.532(3)° β=84.218(3)° γ=78.747(3)°
Pyrimidine derivative
C10H10BrN5O2
Acta Crystallographica Section E (2007) 63, 12 o4535-o4535
a=6.3433(3)Å b=28.9030(8)Å c=6.9439(3)Å
α=90° β=109.821(5)° γ=90°
3-[1-(4-Isobutylphenyl)ethyl]-6-(4-methylphenyl)-1,2,4- triazolo[3,4-b][1,3,4]thiadiazole
C22H24N4S
Acta Crystallographica Section E (2008) 64, 6 o1076-o1077
a=7.25450(10)Å b=8.17640(10)Å c=17.6556(3)Å
α=97.5390(10)° β=96.7120(10)° γ=106.0240(10)°
5-(4,5-Dimethoxy-2-nitrophenyl)-1,3-diphenyl-2-pyrazoline
C23H21N3O4
Acta Crystallographica Section E (2007) 63, 8 o3402-o3402
a=36.0919(7)Å b=13.43720(10)Å c=8.8190(2)Å
α=90° β=104.0990(10)° γ=90°
Ethyl 4-(4,5-dimethoxy-2-nitrophenyl)-6-methyl-1-phenyl-2-thioxo-1,2,3,4-\ tetrahydropyrimidine-5-carboxylate
C22H23N3O6S
Acta Crystallographica Section E (2007) 63, 8 o3403-o3403
a=8.1475(8)Å b=10.3588(10)Å c=14.8263(15)Å
α=86.620(2)° β=78.262(2)° γ=68.395(2)°
4-chloro-N'-{(1Z)-[4-(dimethylamino)phenyl] methylene}4-nitrobenzohydrazide
C16H16N4O3,H2O
Acta Crystallographica Section E (2008) 64, 10 o1907-o1908
a=6.5866(2)Å b=7.1337(2)Å c=34.4059(12)Å
α=92.113(2)° β=90.918(2)° γ=107.8160(10)°
N'-[(E)-1-phenylethylidene]benzohydrazide
C15H14N2O
Acta Crystallographica Section E (2008) 64, 10 o1961-o1962
a=8.2237(6)Å b=5.5938(4)Å c=52.839(4)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(E)-4-Bromobenzylidene]-2-(4-isobutylphenyl)propanohydrazide
C20H23BrN2O
Acta Crystallographica Section E (2009) 65, 6 o1184-o1185
a=9.14400(10)Å b=12.01100(10)Å c=33.5670(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2,4-difluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C14H14F2N2O3
Acta Crystallographica Section E (2009) 65, 6 o1188-o1189
a=7.51760(10)Å b=8.04830(10)Å c=11.9323(2)Å
α=90.1470(10)° β=100.8390(10)° γ=108.4210(10)°
<i>N</i>'-[(<i>E</i>)-4-Chlorobenzylidene]-2-(4-isobutylphenyl)propanohydrazide
C20H23ClN2O
Acta Crystallographica Section E (2009) 65, 6 o1196-o1197
a=9.14050(10)Å b=11.9260(2)Å c=33.3487(5)Å
α=90.00° β=90.00° γ=90.00°
4-[(<i>E</i>)-4-Bromobenzylideneamino]-3-[1-(4-isobutylphenyl)ethyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C21H23BrN4S
Acta Crystallographica Section E (2009) 65, 6 o1340-o1341
a=5.5791(2)Å b=11.3052(3)Å c=17.3688(4)Å
α=75.4210(10)° β=86.6140(10)° γ=79.6160(10)°
4-{[(<i>E</i>)-(4-Chlorophenyl)methylidene]amino}-3-{2-[4-(2- methylpropyl)phenyl]ethyl}-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C21H23ClN4S
Acta Crystallographica Section E (2009) 65, 6 o1242-o1243
a=13.1781(2)Å b=23.7731(4)Å c=30.8550(5)Å
α=92.8610(10)° β=101.5200(10)° γ=92.2540(10)°
Ethyl 4-[3,5-bis(trifluoromethyl)phenyl]-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate
C16H14F6N2O3
Acta Crystallographica Section E (2009) 65, 6 o1404-o1405
a=12.6876(2)Å b=7.30730(10)Å c=19.9547(3)Å
α=90.00° β=114.4430(10)° γ=90.00°
(4-Methylphenyl)[1-(4-methylphenyl)-3-(5-nitro-2-furyl)-1<i>H</i>-pyrazol- 4-yl]methanone
C22H17N3O4
Acta Crystallographica Section E (2009) 65, 12 o3099-o3100
a=9.6398(2)Å b=9.9160(2)Å c=10.1815(2)Å
α=88.0510(10)° β=85.9300(10)° γ=70.4950(10)°
5-Bromo-2-[5-(4-nitrophenyl)-3-phenyl-4,5-dihydro-1<i>H</i>- pyrazol-1-yl]pyrimidine
C19H14BrN5O2
Acta Crystallographica Section E (2009) 65, 12 o3134-o3135
a=6.97090(10)Å b=11.6500(2)Å c=12.4365(2)Å
α=114.9690(10)° β=103.3030(10)° γ=91.5600(10)°
4-[(4-Chlorophenyl)(5-hydroxy-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)methyl]- 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one
C27H23ClN4O2
Acta Crystallographica Section E (2008) 64, 12 o2301-o2302
a=10.8809(2)Å b=11.2046(2)Å c=18.9376(3)Å
α=90.00° β=97.9940(10)° γ=90.00°
2-[4-(2-Methylpropyl)phenyl]-<i>N</i>'-[(E)-1-phenylethylidene]propanehydrazide
C21H26N2O
Acta Crystallographica Section E (2008) 64, 12 o2377
a=5.4355(2)Å b=10.2850(4)Å c=17.3095(6)Å
α=80.821(4)° β=84.312(3)° γ=74.719(3)°
Ethyl 4-(4-methoxyphenyl)-2-oxo-6-phenylcyclohex-3-ene-1-carboxylate
C22H22O4
Acta Crystallographica Section E (2008) 64, 12 o2448
a=9.6095(2)Å b=12.5386(3)Å c=15.9704(3)Å
α=75.9160(10)° β=78.8790(10)° γ=88.4130(10)°
<i>N</i>-(2,4-Dioxo-1,3-thiazolidin-3-yl)-2-(4-isobutylphenyl)propanamide
C16H20N2O3S
Acta Crystallographica Section E (2009) 65, 9 o2094
a=9.73050(10)Å b=11.3991(2)Å c=29.6323(4)Å
α=90° β=90° γ=90°
4-[(4-Fluorobenzylidene)amino]-3-[1-(4-isobutylphenyl)ethyl]-1<i>H</i>- 1,2,4-triazole-5(4<i>H</i>)-thione
C21H23FN4S
Acta Crystallographica Section E (2009) 65, 9 o2079-o2080
a=5.78830(10)Å b=9.90010(10)Å c=18.4972(3)Å
α=98.1320(10)° β=97.0870(10)° γ=105.9970(10)°
4-Hydrazino-2-(methylsulfanyl)pyrimidine
C5H8N4S
Acta Crystallographica Section E (2009) 65, 2 o422
a=12.7906(2)Å b=7.77310(10)Å c=14.4354(3)Å
α=90° β=90° γ=90°
3-{1-[4-(2-Methylpropyl)phenyl]ethyl}-1-(morpholinomethyl)-4-(4-nitrobenzylideneamino)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C26H32N6O3S
Acta Crystallographica Section E (2009) 65, 3 o495-o496
a=10.31040(10)Å b=16.9650(2)Å c=17.1863(2)Å
α=62.6560(10)° β=79.9070(10)° γ=78.3070(10)°
Ethyl 2-[(<i>E</i>)-4-(dimethylamino)benzylidenehydrazino]-5-nitrobenzoate
C18H20N4O4
Acta Crystallographica Section E (2008) 64, 12 o2286-o2287
a=10.8216(4)Å b=15.9175(6)Å c=10.4136(4)Å
α=90.00° β=107.091(2)° γ=90.00°
<i>N</i>'-[(<i>Z</i>)-4-Methylbenzylidene]-4-nitrobenzohydrazide monohydrate
C15H13N3O3,H2O
Acta Crystallographica Section E (2008) 64, 12 o2338
a=6.53870(10)Å b=6.97300(10)Å c=15.9064(3)Å
α=80.5240(10)° β=82.6280(10)° γ=85.0360(10)°
3-[1-(4-Isobutylphenyl)ethyl]-4-[(<i>E</i>)-4-methylbenzylideneamino]- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C22H26N4S
Acta Crystallographica Section E (2008) 64, 12 o2313-o2314
a=7.7614(2)Å b=10.7649(2)Å c=12.9552(2)Å
α=85.9000(10)° β=78.5750(10)° γ=72.5420(10)°
[3-(4-Chlorophenyl)-5-hydroxy-5-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-1-yl](3- pyridyl)methanone
C21H16ClN3O2
Acta Crystallographica Section E (2008) 64, 12 o2363-o2364
a=7.59160(10)Å b=9.76440(10)Å c=12.5474(2)Å
α=104.4240(10)° β=94.9600(10)° γ=96.0810(10)°
3-Benzamidomethyl-4-[(<i>E</i>)-2-chlorobenzylideneamino]-1<i>H</i>-1,2,4- triazole-5(4<i>H</i>)-thione
C17H14ClN5OS
Acta Crystallographica Section E (2009) 65, 1 o48
a=17.0185(6)Å b=8.0905(3)Å c=12.8292(5)Å
α=90.00° β=105.962(2)° γ=90.00°
Rac-2-Bromo-3-ethoxy-1,3-bis(4-methoxyphenyl)propan-1-one
C19H21BrO4
Acta Crystallographica Section E (2009) 65, 1 o19
a=12.2734(10)Å b=15.3432(12)Å c=10.4381(8)Å
α=90.00° β=114.399(4)° γ=90.00°
3-[1-(4-Isobutylphenyl)ethyl]-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C14H19N3S
Acta Crystallographica Section E (2009) 65, 3 o618
a=12.0905(2)Å b=8.44080(10)Å c=14.3189(2)Å
α=90.00° β=98.3650(10)° γ=90.00°
1-[2-(4-Isobutylphenyl)propanoyl]thiosemicarbazide
C14H21N3OS
Acta Crystallographica Section E (2009) 65, 3 o621
a=5.53470(10)Å b=10.6209(3)Å c=13.1435(3)Å
α=97.9350(10)° β=98.4180(10)° γ=96.2930(10)°
2-Bromo-3-phenyl-1-(3-phenylsydnon-4-yl)prop-2-en-1-one
C17H11BrN2O3
Acta Crystallographica Section E (2010) 66, 5 o1225-o1226
a=15.0512(5)Å b=5.9887(2)Å c=22.3940(6)Å
α=90.00° β=129.444(2)° γ=90.00°
4-Formyl-3-<i>p</i>-tolylsydnone
C10H8N2O3
Acta Crystallographica Section E (2010) 66, 6 o1303
a=10.5663(4)Å b=10.4088(3)Å c=8.9630(3)Å
α=90.00° β=108.2220(10)° γ=90.00°
4-[4-Ethoxycarbonyl-5-(3,4-methylenedioxyphenyl)- 3-oxocyclohex-1-en-1-yl]-3-phenylsydnone
C24H20N2O7
Acta Crystallographica Section E (2010) 66, 9 o2367-o2368
a=8.8026(2)Å b=11.5133(2)Å c=11.6981(2)Å
α=66.8600(10)° β=86.5450(10)° γ=71.1150(10)°
4-({[6-(4-Chlorobenzyl)-4-methyl-5-oxo-4,5-dihydro-1,2,4-triazin-3- yl]sulfanyl}acetyl)-3-phenylsydnone
C21H16ClN5O4S
Acta Crystallographica Section E (2011) 67, 4 o820
a=6.46040(10)Å b=10.1634(2)Å c=16.9901(4)Å
α=105.2640(10)° β=92.1030(10)° γ=97.3630(10)°
(4-Methylphenyl)[3-(5-nitro-2-furyl)-1-phenyl-1<i>H</i>-pyrazol-4-yl]methanone
C21H15N3O4
Acta Crystallographica Section E (2009) 65, 12 o3088-o3089
a=11.3859(2)Å b=7.5746(2)Å c=21.0008(4)Å
α=90.00° β=107.2020(10)° γ=90.00°
2,5-Bis(4-methoxyphenyl)-1,3,4-oxadiazole
C16H14N2O3
Acta Crystallographica Section E (2010) 66, 12 o3072
a=10.7525(2)Å b=11.8973(2)Å c=11.6340(2)Å
α=90.00° β=115.4340(10)° γ=90.00°
8-Chloro-5,5-dimethyl-5,6-dihydrotetrazolo[1,5-<i>c</i>]quinazoline
C10H10ClN5
Acta Crystallographica Section E (2010) 66, 12 o3219
a=6.8324(16)Å b=21.532(5)Å c=9.4337(16)Å
α=90.00° β=130.823(11)° γ=90.00°
2,3-Dibromo-3-(5-nitro-2-furyl)-1-(4-nitrophenyl)propan-1-one
C13H8Br2N2O6
Acta Crystallographica Section E (2010) 66, 12 o3128
a=12.1902(2)Å b=12.2006(2)Å c=9.9761(2)Å
α=90.00° β=96.2820(10)° γ=90.00°
2,3-Dibromo-3-(2-bromophenyl)-1-(3-phenylsydnon-4-yl)propan-1-one
C17H11Br3N2O3
Acta Crystallographica Section E (2010) 66, 12 o3094
a=29.0105(16)Å b=7.2271(4)Å c=17.7209(9)Å
α=90.00° β=102.591(2)° γ=90.00°
2,3-Dibromo-1-(4-chlorophenyl)-3-(5-nitro-2-furyl)propan-1-one
C13H8Br2ClNO4
Acta Crystallographica Section E (2010) 66, 12 o3220
a=8.4932(11)Å b=9.4501(12)Å c=10.5665(14)Å
α=92.731(2)° β=107.000(2)° γ=114.299(2)°
4-[(3-Benzamidomethyl-6-phenyl-6,7-dihydro-5<i>H</i>-1,2,4- triazolo[3,4-<i>b</i>][1,3,4]thiadiazin-7-yl)carbonyl]-3-phenyl- 1,2,3-oxadiazol-3-ium-5-olate 0.06-hydrate
C27H21N7O4S,0.06(H2O)
Acta Crystallographica Section E (2011) 67, 1 o128-o129
a=15.6242(19)Å b=18.7430(19)Å c=18.9689(19)Å
α=111.235(2)° β=93.970(2)° γ=101.636(2)°
(<i>E</i>)-<i>N'</i>-(2-Hydroxybenzylidene)-2-(4-isobutylphenyl)propanohydrazide
C20H24N2O2
Acta Crystallographica Section E (2010) 66, 1 o24
a=5.5017(2)Å b=33.0204(14)Å c=9.7279(4)Å
α=90.00° β=91.731(3)° γ=90.00°
(4-Chlorophenyl)[1-(4-methoxyphenyl)-3-(5-nitro-2-furyl)-1<i>H</i>- pyrazol-4-yl]methanone
C21H14ClN3O5
Acta Crystallographica Section E (2010) 66, 5 o1063-o1064
a=9.5589(8)Å b=9.6603(8)Å c=10.6401(9)Å
α=95.523(2)° β=91.074(2)° γ=107.706(2)°
3-(5-Nitro-2-furyl)-1-phenylprop-2-yn-1-one
C13H7NO4
Acta Crystallographica Section E (2010) 66, 11 o3031-o3032
a=10.4685(2)Å b=7.30060(10)Å c=15.2642(2)Å
α=90.00° β=110.8670(10)° γ=90.00°
4-{3-[(2-Isopropyl-5-methylphenoxy)methyl]-7<i>H</i>-1,2,4-triazolo[3,4- <i>b</i>][1,3,4]thiadiazin-6-yl}-3-(<i>p</i>-tolyl)sydnone
C24H24N6O3S
Acta Crystallographica Section E (2010) 66, 9 o2198-o2199
a=16.7814(3)Å b=7.29010(10)Å c=20.2221(3)Å
α=90.00° β=106.9910(10)° γ=90.00°
2-(3-Oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl)acetic acid monohydrate
C10H9NO3S,H2O
Acta Crystallographica Section E (2009) 65, 10 o2358-o2359
a=7.58970(10)Å b=9.2208(2)Å c=15.6701(3)Å
α=90.00° β=94.3360(10)° γ=90.00°
<i>N</i>'-[(E)-1-(4-Chlorophenyl)ethylidene]-2-[4-(2- methylpropyl)phenyl]propanohydrazide
C21H25ClN2O
Acta Crystallographica Section E (2009) 65, 1 o17-o18
a=14.2691(2)Å b=15.5343(2)Å c=20.7436(3)Å
α=77.4160(10)° β=90.0580(10)° γ=62.7140(10)°
2-phenyl-1H-pyrazol-3(2H)-one ethanol hemisolvate
C27H24N4O2,0.5(C2H6O)
Acta Crystallographica Section E (2009) 65, 1 o66-o67
a=8.3767(2)Å b=13.9498(3)Å c=20.4797(4)Å
α=101.0740(10)° β=93.7230(10)° γ=93.5790(10)°
2-(4-Isobutylphenyl)-<i>N</i>'-[1-(4-nitrophenyl)ethylidene]propanohydrazide
C21H25N3O3
Acta Crystallographica Section E (2009) 65, 3 o445
a=13.7343(2)Å b=7.9039(2)Å c=20.8408(3)Å
α=90.00° β=122.6770(10)° γ=90.00°
4-[(<i>E</i>)-4-Methoxybenzylideneamino]-3-{1-[4-(2-methylpropyl)phenyl]ethyl}-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C22H26N4OS
Acta Crystallographica Section E (2009) 65, 5 o1149-o1150
a=7.94460(10)Å b=11.1392(2)Å c=12.3797(2)Å
α=77.7690(10)° β=79.0250(10)° γ=80.0630(10)°
Ethyl 4-(2,4-difluorophenyl)-6-methyl-1-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C20H18F2N2O2S
Acta Crystallographica Section E (2009) 65, 5 o981-o982
a=11.3019(2)Å b=13.9550(2)Å c=24.3463(4)Å
α=98.8070(10)° β=93.7760(10)° γ=102.5060(10)°
Ethyl 4-(5-chloro-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-6-methyl-2-oxo- 1,2,3,4-tetrahydropyrimidine-5-carboxylate
C18H19ClN4O3
Acta Crystallographica Section E (2009) 65, 6 o1229
a=7.9083(2)Å b=10.2600(2)Å c=10.9075(3)Å
α=93.3940(10)° β=99.3790(10)° γ=90.2030(10)°
Ethyl 6-(4-chlorophenyl)-4-(4-methoxyphenyl)-2-oxocyclohex-3-ene-1-carboxylate
C22H21ClO4
Acta Crystallographica Section E (2009) 65, 6 o1235
a=11.9729(3)Å b=8.1713(2)Å c=39.2033(8)Å
α=90° β=98.9900(10)° γ=90°
(<i>E</i>)-3-Methyl-4-[(2-oxidoquinolin-1-ium-3-yl)methyleneamino]- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione <i>N</i>,<i>N</i>-dimethylformamide solvate
C13H11N5OS,C3H7NO
Acta Crystallographica Section E (2009) 65, 12 o3235-o3236
a=7.23740(10)Å b=23.4970(4)Å c=10.8214(2)Å
α=90.00° β=107.8200(10)° γ=90.00°